TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06861361: Surgical Bioprosthesis Aortic Valve Replacement Vs. Myval Balloon-Expandable THV Series in Patients Aged 65 to 75 With Symptomatic Severe Aortic Stenosis Judged Eligible by Heart Team

Sponsor: Ceric Sàrl · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1180 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,640,000

Rescue Site Savings

+$4,382,400

Unlock Full NCT06861361 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06861361 Rescue Dossier →